BIOANALYTICS
CRS‘ wide range of analytical capabilities
CRS collaborates with several well-established bioanalytical laboratories, providing solutions for the entire drug development process, whether small or large molecules are involved.
To this end, CRS offers a wide range of analytical capabilities. These include, among others, the characterization of New Molecular Entities (NME), the study of metabolism and metabolites, standard safety profiles formation, and biomarker research.
REACHING OUT IS EASY AND FAST – LET’S TALK
Chairman of the Executive Board
located at CRS Mannheim
VP & Head of Business Development
located at CRS Management
CRO Leadership Awards 2019
CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.
European Biotechnology Guide
Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.
EcoVadis – CSR Rating
Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.